Analyst Research: Pfizer Inc (PFE)

PFE on New York Consolidated

28.89USD
20 Aug 2014
Price Change (% chg)

$-0.05 (-0.17%)
Prev Close
$28.94
Open
$28.83
Day's High
$28.98
Day's Low
$28.74
Volume
15,032,899
Avg. Vol
23,582,790
52-wk High
$32.96
52-wk Low
$27.76

Search Stocks
Reports per page
Select Report Title Date Provider Pgs Price
Thomson Reuters Stock Report - PFIZER INC. (PFE-N) 6:19am EDT Thomson Reuters Stock Report 12 25.00
Trading Report for (PFE). A detailed report, including free correlated market analysis, and updates. 2:14am EDT Stock Traders Daily 10 20.00
PFE: Due Diligence Review: Forensic Earnings and Valuation 19 Aug 2014 New Constructs, LLC 9 25.00
"The Economy Matters" Report for PFE: the economy's impact on PFE's price and risk, featuring the powerful Economic Climate Rating 18 Aug 2014 MacroRisk Analytics/EconomicInvestor 7 25.00
ValuEngine Rating and Forecast Report for PFE 17 Aug 2014 ValuEngine, Inc. 11 25.00
Wright Investors Service Comprehensive Report for Pfizer Inc. 17 Aug 2014 Wright Reports 59 75.00
Pfizer, Inc 16 Aug 2014 S&P Capital IQ – STARS Reports 11 127.00
Our Economy without Stimulus; forward observations. 15 Aug 2014 Stock Traders Daily 102 20.00
PFIZER INC (PFE) 12-months forecast 15 Aug 2014 Pechala's Reports 1 15.00
PFIZER INC (PFE) - REPORT FOR ACTIVE TRADERS 15 Aug 2014 Pechala's Reports 1 25.00
 
Name Age Since Current Position

Ian Read

60 2011 Chairman of the Board, Chief Executive Officer

Frank D'Amelio

56 2010 Chief Financial Officer, Executive Vice President - Business Operations

Albert Bourla

52 2014 Group President - Vaccines, Oncology and Consumer Healthcare Business

Mikael Dolsten

55 2010 President - Worldwide Research and Development

Geno Germano

53 2014 Group President - Global Innovative Pharma Business
Search Stocks